Others claim that the costs of transfusion alternatives are too high, although reports are emerging that prove otherwise.
Väidetakse ka, et vereülekande alternatiivide hinnad on liiga kõrged, olgugi et üha on lisandumas vastupidist tõendavaid aruandeid.